Imugene Ltd


Has acquired the balance of the outstanding share capital in its production animal subsidiary, VectoGen Ltd.  The consideration for the acquisition comprises the issue of 14,745,433 new ordinary Imugene shares and the issue of 8,872 convertible preference shares.  On settlement of the acquisition agreements with the various VectoGen shareholders, Imugene will increase its ownership from 40% to 100% of VectoGen.

Safe Effect Technologies Ltd


Has now entered into a Share Acquisition Agreement with KPN Group for the acquisition from KPN of a controlling interest of 51% of Siam Adler Co Ltd for cash consideration of US$1.7 million.

Add your comment

BNIQ sponsored byECU School of Business and Law


6th-Australian Institute of Management WA20,000
7th-Murdoch University16,584
8th-South Regional TAFE10,549
9th-Central Regional TAFE10,000
10th-The University of Notre Dame Australia6,708
48 tertiary education & training providers ranked by total number of students in WA

Number of Employees

BNiQ Disclaimer